Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.33 |
| ▸ | SELE | P16581 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR3A | P46098 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2253699 | 1.00 | MAPT (0.40) | MAPTALDH1A1POLBGAATSHR | |
| SCHEMBL14919249 | 0.98 | MAPT (0.41) | MAPTALDH1A1POLBGAATSHR | |
| SCHEMBL9869690 | 0.82 | MAPT (0.44) | MAPTALDH1A1POLBGAAHTR7 | |
| SCHEMBL9824740 | 0.77 | IDO1 (0.46) | MAPTALDH1A1TSHRACHEHAO1 | |
| SCHEMBL7162341 | 0.77 | TSHR (0.38) | MAPTALDH1A1POLBGAATSHR | |
| SCHEMBL28454128 | 0.77 | ACHE (0.38) | MAPTALDH1A1POLBGAATSHR | |
| Formic Acid SCHEMBL28866198 | 0.73 | MAPT (0.38) | MAPTALDH1A1POLBGAATSHR | |
| SCHEMBL21807618 | 0.72 | PKM (0.44) | MAPTALDH1A1TSHRHAO1HTR3A | |
| SCHEMBL1080945 | 0.72 | ACHE (0.45) | MAPTALDH1A1GAAACHE | |
| SCHEMBL29067024 | 0.72 | ALDH1A1 (0.50) | MAPTALDH1A1POLBGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260101901-A1 | DELAYING BLOOM IN HORTICULTURAL CROPS USING JASMONIC ACID BIOSYNTHESIS INHIBITORS | VIRGINIA TECH INTELLECTUAL PROPERTIES INC (US) | 2026-04-16 | — | — | US | disclosed |
| WO-2024073357-A1 | DELAYING BLOOM IN HORTICULTURAL CROPS USING JASMONIC ACID BIOSYNTHESIS INHIBITORS | VIRGINIA TECH INTELLECTUAL PROPERTIES INC. (US) | 2024-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260101901-A1 | DELAYING BLOOM IN HORTICULTURAL CROPS USING JASMONIC ACID BIOSYNTHESIS INHIBITORS | FADS2, DDT, MYB | MAPT 1357/4885ALDH1A1 2084/4885POLB 3978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.